2021 Global Drug Bioavailability Enhancement Summit

9:00am - 4:00pm EDT November 3rd - 4th, 2021 | Virtual / On-Demand Summit

REGISTER      AGENDA

2021 Global Drug Bioavailability Enhancement Summit

9:00am - 4:00pm EDT November 3rd - 4th, 2021 | Virtual / On-Demand Summit

REGISTER      AGENDA

2021 Global Drug Bioavailability Enhancement Summit

9:00am - 4:00pm EDT November 3rd - 4th, 2021 | Virtual / On-Demand Summit

REGISTER      AGENDA

2021 Global Drug Bioavailability Enhancement Summit

9:00am - 4:00pm ET Nov 3 - 4, 2021 | Virtual / On-Demand Summit

2021 Global Drug Bioavailability Enhancement Summit

9:00am - 4:00pm ET Nov 3 - 4, 2021 | Virtual / On-Demand Summit

2021 Global Drug Bioavailability Enhancement Summit

9:00am - 4:00pm ET Nov 3 - 4, 2021 | Virtual / On-Demand Summit

Save an additional 15% on registration with code SITE15. Early-bird expires in:

Day(s)

:

Hour(s)

:

Minute(s)

:

Second(s)

Day One Virtual Summit – Wednesday, 3rd November 2021

9:15am
Chair’s Welcome Introduction & House Rules
Simon Curtis

Simon Curtis

Co-Founder & Chief Executive Officer

Curtis & Coulter

9:30am
Model-Based Approaches for Evaluating and Modifying Oral Bioavailability
Arijit Chakravarty, PhD

Arijit Chakravarty, PhD

Chief Executive Officer

Fractal Therapeutics

10:00am

SUMMIT NETWORKING SLOT

Explore the Summit virtual platform, schedule meetings, connect with fellow Summit attendees, and visit the Global Drug Bioavailability Enhancement Summit partner CDMOs and technology companies.

10:10am
OptiForm® Solution Suite – Catalent’s Early Development Toolkit for Resolving Small Molecule Oral Bioavailability Challenges in Preclinical Phase
• Material Characterization tools to help determine when solubility may be difficult
• PBPK modelling to review permeability and other absorption challenges
• Beginning the transition from API to drug product using material sparing and risk mitigating approaches in animal PK evaluations
• Case examples showing the benefit of working with an experienced CDMO
• Faster to Phase 1 with dosage form flexibility
Stephen Tindal, PhD

Stephen Tindal, PhD

Director, Science & Technology

Catalent

Sponsored by:

10:40am

SUMMIT NETWORKING SLOT

Explore the Summit virtual platform, schedule meetings, connect with fellow Summit attendees, and visit the Global Drug Bioavailability Enhancement Summit partner CDMOs and technology companies.

10:50am
Overcoming Bioavailability Challenges of Peptide-Based Drug Product Development
Saji Vijayan, PhD

Saji Vijayan, PhD

Vice President- R&D Strategy

Endo Pharmaceuticals

11:20am

SUMMIT NETWORKING SLOT

Explore the Summit virtual platform, schedule meetings, connect with fellow Summit attendees, and visit the Global Drug Bioavailability Enhancement Summit partner CDMOs and technology companies.

11:30am
Electrospinning as a Manufacturing Technique for Enabling Formulations
Sune Anderson, PhD

Sune Anderson, PhD

Principal Scientist, Spray Drying

Johnson & Johnson

12:00pm

SUMMIT NETWORKING SLOT

Explore the Summit virtual platform, schedule meetings, connect with fellow Summit attendees, and visit the Global Drug Bioavailability Enhancement Summit partner CDMOs and technology companies.

12:10pm
V-Smart®: Novel Non-Invasive, Brain-Targeted Drug Delivery Platform
Susan Rosenbaum, JD

Susan Rosenbaum, JD

Founder & Chief Executive Officer

Lauren Sciences

12:40pm

Virtual Lunch break

Grab a snack explore the Summit virtual platform, engage fellow attendees, and visit the Global Drug Bioavailability Enhancement Technology and Service companies solutions pages. Likewise, connect with other Summit attendees through our chat and networking portals.

1:30pm
Long Acting Injectables and Biopharmaceutics Implications
Manish Gupta, PhD

Manish Gupta, PhD

Senior Director, Sterile Drug Product Development, Pharmaceutical Development

GlaxoSmithKline

2:00pm

SUMMIT NETWORKING SLOT

Explore the Summit virtual platform, schedule meetings, connect with fellow Summit attendees, and visit the Global Drug Bioavailability Enhancement Summit partner CDMOs and technology companies.

2:10pm
Improving Oral Bioavailability whilst Accelerating Product Development to the Clinic
Sudhakar Garad, PhD

Sudhakar Garad, PhD

Global Head of Chemical and Pharmaceutical Profiling

Novartis

2:40pm

SUMMIT NETWORKING SLOT

Explore the Summit virtual platform, schedule meetings, connect with fellow Summit attendees, and visit the Global Drug Bioavailability Enhancement Summit partner CDMOs and technology companies.

2:50pm
The Development of Oligonucleotide / Polymeric Carrier Formulation
Di Wu, PhD

Di Wu, PhD

Senior Scientist, Formulation Development

Merck & Co., Inc.

3:20pm

SUMMIT NETWORKING SLOT

Explore the Summit virtual platform, schedule meetings, connect with fellow Summit attendees, and visit the Global Drug Bioavailability Enhancement Summit partner CDMOs and technology companies.

3:30pm
Computer-Aided Prodrug Design
Dedong Wu, PhD

Dedong Wu, PhD

Senior Scientist, Solid State

AstraZeneca

3:55pm

SUMMIT NETWORKING SLOT

Explore the Summit virtual platform, schedule meetings, connect with fellow Summit attendees, and visit the Global Drug Bioavailability Enhancement Summit partner CDMOs and technology companies.

4:00pm

Chair’s Closing Remarks & Close of Day One
Simon Curtis

Simon Curtis

Co-Founder & Chief Executive Officer

Curtis & Coulter

Day Two Virtual Summit – Thursday 4th November, 2021

9:15am
Chair’s Welcome Introduction
Simon Curtis

Simon Curtis

Co-Founder & Chief Executive Officer

Curtis & Coulter

9:30am
Innovations within Characterization of Amorphous Materials to Advance Product Development
Eric Munson, PhD

Eric Munson, PhD

Patrick DeLuca Endowed Professor in Pharmaceutical Technology, Department of Pharmaceutical Sciences

Purdue University

10:00am

SUMMIT NETWORKING SLOT

Explore the Summit virtual platform, schedule meetings, connect with fellow Summit attendees, and visit the Global Drug Bioavailability Enhancement Summit partner CDMOs and technology companies.

10:10am

Bioavailability Enhancing Cocrystals: Screening, In Vivo Predictive Dissolution, and Supersaturation Maintenance
Dabing Chen, PhD

Dabing Chen, PhD

Senior Principal Scientist

Boehringer Ingelheim

10:40am

SUMMIT NETWORKING SLOT

Explore the Summit virtual platform, schedule meetings, connect with fellow Summit attendees, and visit the Global Drug Bioavailability Enhancement Summit partner CDMOs and technology companies.

10:50am
Challenges in Development of Highly Drug Loaded, Redispersible API Nanoparticle Containing Tablets
Christoph Nüboldt

Christoph Nüboldt

Senior Researcher

INVITE GmbH

11:20am

SUMMIT NETWORKING SLOT

Explore the Summit virtual platform, schedule meetings, connect with fellow Summit attendees, and visit the Global Drug Bioavailability Enhancement Summit partner CDMOs and technology companies.

11:30am

A Novel Lymphatic/Brain Targeting Macromolecular Prodrug System
Stephen Stern, PhD

Stephen Stern, PhD

Director of Research and Development, Head of the Pharmacology and Toxicology Section

Nanotechnology Characterization Laboratory

12:00pm

SUMMIT NETWORKING SLOT

Explore the Summit virtual platform, schedule meetings, connect with fellow Summit attendees, and visit the Global Drug Bioavailability Enhancement Summit partner CDMOs and technology companies.

12:10pm

Expanding QC Dissolution Through Human Relative Bioavailability Study of a Slowly Eroding Amorphous Solid Dispersion Tablet
Melanie Marota, PhD

Melanie Marota, PhD

Associate Principal Scientist, Pharmaceutical Sciences

Merck & Co.

12:40pm

Virtual Lunch break

Grab a snack explore the Summit virtual platform, engage fellow attendees, and visit the Global Drug Bioavailability Enhancement Technology and Service companies solutions pages. Likewise, connect with other Summit attendees through our chat and networking portals.

1:30pm

Oral Bioavailability Enhancement via Supersaturation and Precipitation
Ajit Narang, PhD

Ajit Narang, PhD

Principal Scientist, Small Molecule Pharmaceutics and Biopharmaceutics

Genentech

1:55pm

SUMMIT NETWORKING SLOT

Explore the Summit virtual platform, schedule meetings, connect with fellow Summit attendees, and visit the Global Drug Bioavailability Enhancement Summit partner CDMOs and technology companies.

2:00pm

Melt Extrusion Deposition (MED®) 3D Printing for the Challenging Pharmaceutical Products
Xin Liu, PhD

Xin Liu, PhD

Associate Director of Pharmaceutical Product Development

Triasek

2:25pm

SUMMIT NETWORKING SLOT

Explore the Summit virtual platform, schedule meetings, connect with fellow Summit attendees, and visit the Global Drug Bioavailability Enhancement Summit partner CDMOs and technology companies.

2:30pm

Bespoke Dosing for Pediatric Patients
Rick Panicucci, PhD

Rick Panicucci, PhD

Senior Vice President, CMC

QED Therapeutics

2:55pm

SUMMIT NETWORKING SLOT

Explore the Summit virtual platform, schedule meetings, connect with fellow Summit attendees, and visit the Global Drug Bioavailability Enhancement Summit partner CDMOs and technology companies.

3:00pm

Mesoporous Silica Technology: A Solubility Enhancement Oral Delivery System for Poorly Soluble Drugs
Shih-Wen Wang, PhD

Shih-Wen Wang, PhD

Senior Associate Scientist

Pfizer

3:20pm

Chair’s Closing Remarks & End of Summit
Simon Curtis

Simon Curtis

Co-Founder & Chief Executive Officer

Curtis & Coulter

Attend

Meet 120+ drug development professionals & learn over 2 YEARS worth of new product development strategies, formulation approaches, delivery technologies & regulatory updates while decreasing drug product time-to-market in just 3 days!

Sponsorship

Take advantage of the unique opportunity to engage your direct target audience face-to-face, and help them overcome their product challenges in 2 full interactive days!

Convince Your Boss

Want to attend but need help convincing your boss? Let us generate you a custom message for you to send to your boss. Email it, talk them through it in person, tweet it: It’s up to you! 

Pin It on Pinterest

Share This